Tech Company Financing Transactions
Nanotherapeutics Funding Round
Nanotherapeutics secured a $30 million funding round on 6/4/2014. Investors included Hercules Technology Growth Capital.
Transaction Overview
Company Name
Announced On
6/4/2014
Transaction Type
Debt
Amount
$30,000,000
Round
Undisclosed
Investors
Proceeds Purpose
The funds from the loan facility will support the Company's efforts to expand its manufacturing infrastructure.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
13859 Progress Blvd. 300
Alachua, FL 32615
USA
Alachua, FL 32615
USA
Phone
Website
Email Address
Overview
Nanotherapeutics is a privately-held emerging biopharmaceutical company with both proprietary platform technologies and a diversified pipeline of products.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
James Talton
Chief Financial Officer
James Matthew
Chief Medical Officer
Carl Kraus
VP - Bus. Development
Bärbel Eppler
VP - Operations
Dennis Tomisaka
VP - R & D
James Kirk
Browse more venture capital transactions:
Prev: 6/4/2014: Bespoke Global venture capital transaction
Next: 6/4/2014: Spinal Kinetics venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on all VC transactions involving tech companies. VC transactions reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs